Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs

Mini-Reviews in Medicinal Chemistry

Volumn 5, Issue 3, 2005, Pages 293-305

  Irache, J M ^a   Merodio, M ^a   Arnedo, A ^a   Camapanero, M A ^b   Mirshahi, M ^c   Espuelas, S ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c INSERM   (France)

Author keywords

Albumin; Fomivirsen; Ganciclovir; Intravitreal delivery; Nanoparticles; Oligonucleotides; Retinitis

Indexed keywords

ALBUMIN; ANTIVIRUS AGENT; BIOTIN; DRUG CARRIER; FOMIVIRSEN; GANCICLOVIR; NANOPARTICLE; VIRUS DNA;

ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; CELL VIABILITY; CONTROLLED RELEASE FORMULATION; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG TARGETING; HUMAN; IN VITRO STUDY; NEUTROPENIA; NONHUMAN; PHYSICAL CHEMISTRY; RETINITIS; REVIEW; THROMBOCYTOPENIA; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 14744297235     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389557053175335     Document Type: Review

References (110)

1. van der Meer, J.T,M.; Drew, W.L.; Bowden, R.A.; Galasso, G.J.; Griffiths, P.D.; Jabs, D.A.; Katlama, C.; Spector, S.A.; Whitley, R.J. Antiviral Res., 1996, 32, 119-140.
2. Nelson, C.T.; Demmler, G.J. Clin. Perinatol., 1997 24, 151-160.
3. Garrett Nichols, W.; Boeckh, M.J. Clin. Virol., 2000 16, 25-40.
4. Noble, S.; Faulds, D. Drugs, 1998, 56, 115-146.
5. Katlama, C.; Burke, M.; Pedersen, C. Eur. J. Clin. Microbiol. Infect. Dis., 1997, 16, 876-882.
6. Kempen, J.H.; Martin, B.K.; Wu, A.W.; Barron, B.; Thorne, J.E.; Jabs, D.A. Ophthalmol., 2003, 110, 987-995.
7. Cantrill, H.L.; Henry, K.; Melroe, N.H.; Knobloch, W.H.; Ramsay, R.C.; Balfour, H.H. Jr. Ophthalmol., 1989, 96, 367-374.
8. Riise, G.C.; Andersson, R.; Bergstrom, T.; Lundmark, A.; Nilsson, F.N.; Olofsson, S. Chest, 2000, 118, 1653-1660
9. Melnick, J.L.; Petrie B.L.; Dreesman G.R.; Burek J.; McCollum C.H.; DeBakey M.E. Lancet, 1983, 17, 644-647.
10. Adam, E.; Melnick, J.L.; DeBakey, M.E. Cent. Eur. J. Public. Health., 1997, 5, 99-106.
11. Hosenpud, J.D.; Shipley, G.D.; Wagner, C.R. J. Heart Lung Transplant., 1992, 11, 9-23.
12. Streblow, D.N.; Kreklywich, C.; Yin, Q.; de la Melena, V.T.; Corless, C.L.; Smith, P.A.; Brakebill, C.; Cook, J.W.; Vink, C.; Bruggeman, C.A.; Nelson, J.A.; Orloff, S.L. J. Virol., 2003, 77, 2182-2194.
13. Ho, M. Transplant. Proc., 1994, 26, 7-11.
14. Paya, C.V.; Wilson, J.A.; Espy, M.J.; Sia, I.G.; de Bernardi, M.J.; Smith, T.F.; Patel, R.; Jenkins, G.; Harmsen, W.S.; Vanness, D.J.; Wiesner, R.H. J. Infect. Dis., 2002, 185, 854-860.
15. Tzakis, A.G. Transplant. Infect. Dis., 2001, 3 35-39.
16. Sageda, S.; Nordal, K.P.; Hartmann, A.; Sund, S.; Scott, H.; Degre, M.; Foss, A.; Leivestad, T.; Osnes, K.; Fauchald, P.; Rollag, H. Am. J. Transplant., 2002, 2, 850-856.
17. Falagas, M.E.; Arbo, M.; Ruthazer, R. Transplant., 1997, 63, 1595-1601.
18. Sinzger, C.; Grefte, A.; Plachter, B.; Gouw, A.S.; The, T.H.; Jahn, G. J. Gen. Virol., 1995, 76, 741-750.
19. Alrabiah, F.A.; Sacks, S.L. Drugs, 1996, 52 17-32.
20. Henderly, D.E.; Freeman, W.R. Ophthalmol., 1987, 94, 425-434.
21. Michel, D.; Schaarschmidt, P.; Wunderlich, K.; Heuschmid, M.; Simoncini, L.; Muhlberger, D.; Zimmermann, A.; Pavic, I.; Mertens, T. J. Gen. Virol., 1998, 79, 2105-2112.
22. Cheng Y.; Huang E.S.; Lin J.; Mar E.; Pagano J.S. J. Biol. Chem., 1983, 258, 12460-12464.
23. Biron, K.K. Proc. Natl. Acad. Sci. U. S. A., 1985 82, 2473-2477.
24. Berthe, P.; Baudoin, C.; Lapalus, P. Invest. Ophthalmol. Vis. Sci., 1994, 35, 1038-1045.
25. Markham, A.; Faulds, D. Drugs, 1994, 48, 455-484.
26. Curran, M.; Noble, S. Drugs, 2001, 61, 1145-1150.
27. Jabs, D.A.; Martin, B.K.; Forman, M.S.; Hubbard, L.; Dunn, M.J.P.; Kempen, J.H.; Davis, J.L.; Weinberg, D.V. Am. J. Ophthalmol. 2003, 135, 26-34.
28. Limaye, A.P. Clin. Infect. Dis., 2002, 35, 866-872.
29. Henry, K.; Cantrill, H.; Flecher, C.; Chinnock, B.J.; Balfour, H.H. Am. J. Ophthalmol., 1987, 103, 17-23.
30. Heinemann, M.H. Am. J. Ophthalmol., 1989, 107 643-644.
31. Cochereau-Massin, I; Lehoang, P.; Lautier-Frau, M. Ophthalmol., 1991, 98, 1348-1355.
32. Asthon, P.; Anand, R.; Nightingale, S.D.; Fish, R.H.; Smith, T.J. Arch. Ophthalmol., 1993, 111, 223-227.
33. Hatton, M.P.; Duker, J.S.; Reichel, E.; Morley, M.G.; Puliafito, C.A. Retina, 1998, 18, 50-55.
34. Le-Bourlais, C.; Chevanne, F.; Ropert, P.; Bretagne, G.; Acar, L,; Leverge, R. J. Microencaps., 1996, 13, 473-480.
35. Refojo, M.F.; Veloso, A.A.S.; Zhu, Q.; Herrero-Vanrell, R. Invest. Opthalmol. Vis. Sci., 1997, 38, 665-675.
36. Charles, N.C.; Steiner, G.C. Ophthalmol., 1996, 103, 416-421.
37. Engstrom, R.E.; Holland, G.N. Am. J. Ophthalmol., 1995, 120, 376-385.
38. Martin, D.F.; Kuppermann, B,D.; Wolitz, R.A.; Palestine, A.G.; Li, H.; Robinson, C.A. N. Engl. J. Med., 1999, 340 1462-1470.
39. De Rojas, M.V.; Rodriguez-Ares, M.T.; Sanchez-Salorio, M.; Lamas, M.J.; Piñeiro, A.; Tutor, J.C.; Vila, J.L.; Cuevas, J. Arch. Soc. Esp. Oftalmol., 1996, 71, 127-132.
40. Refojo, M.F.; Negro, S.; Barcia, E.; Herrero-Vanrell, R. S.T.P. Pharma Sci., 1998, 8, 237-240.
41. Traynor, K. Am. J. Health Syst. Pharm., 2002, 59, 2046-2047.
42. Danis, R.P.; Henry, S.P.; Ciulla, T.A. Expert Opin. Pharmacother., 2001, 2, 277-279.
43. Perry, C.M.; Balfour, J.A. Drugs, 1999, 57 375-380.
44. Geary, R.S.; Henry, S.P.; Grillone, L.R. Clin. Pharmacokinet., 2002, 41, 255-260.
45. Leeds, J.M.; Henry, S.P.; Truong, L.; Zutshi, A.; Levin, A.A.; Kornbrust, D. Drug Metab. Dispos., 1997, 25, 921-926.
46. Lebedeva, I.; Benimetskaya, L.; Stein, C.A.; Vilenchik, M. Eur. J. Pharm. Biopharm., 2000, 50, 101-119.
47. Berton, M.; Allemann, E.; Stein, C.A.; Gurny, R. Eur. J. Pharm. Sci., 1999, 9, 163-170.
48. Lambert, G.; Fattal, E.; Couvreur, P. Adv. Drug Delivery Rev., 2001, 47, 99-112,
49. Kanamaru, T.; Takagi, Y.; Takakura, M.; Hashida, J. J. Drug Targeting, 1998, 5, 235-246.
50. Lebedeva, I.; Stein, C.A. Annu. Rev. Pharmacol. Toxicol. 2001, 41, 403-419.
51. Brigui, I.; Djavanbakht-Samani, T.; Jolles, B.; Pigaglio, S.; Laigle, A. Biochem Pharmacol., 2003, 65, 747-754.
52. Crooke, S.T. Annu. Rev. Pharmacol. Toxicol., 1992 32, 329-376.
53. Wong, F.M.; MacAdam, S.A.; Kim, A.; Oja, C.; Ramsay, E.C.; Bally, M.B. J. Drug Targeting, 2002, 10, 615-623.
54. Kaneda, Y. Adv. Drug Delivery Rev., 2000, 43 197-205.
55. de Oliveira, M.C.; Rosilio, V.; Lesieur, P.; Bourgaux, C.; Couvreur, P.; Ollivon, M.; Dubernet, C. Biophys. Chem., 2000, 87, 127-137.
56. Fresta, M.; Chillemi, R.; Spampinato, S.; Sciuto, S.; Puglisi, G. J. Pharm. Sci., 1998, 87, 616-625.
57. Leserman, L.D.; Barbet, J.; Kourilsky, F.; Weinstein, J.N. Nature, 1980, 288, 602-604.
58. Chavany, C.; Le Doan, T.; Couvreur, P.; Puisieux, F.; Hélène, C. Pharm. Res., 1992, 9, 441-449.
59. Zobel, H.P.; Kreuter, J.; Werner, D.; Noe, C.R.; Kumel, G.; Zimmer, A. Antisense Nucleic Acid Drug Dev., 1997, 7, 483-493.
60. Lambert, G.; Fattal, E.; Brehier, A.; Feger, J.; Couvreur, P. Biochimie, 1998, 80, 969-976.
61. Couvreur, P.; Courraze, G.; Devissaguet, J.P.; Puisieux, P. In Microencapsulation: methods and industrial application; Benita S., Ed.; Marcel Dekker: New York, 1996; pp. 183-211.
62. Soppimath, K.S.; Aminabhavi, T.M.; Kulkarni, A.R.; Rudzinski, W.E. J. Controlled Release, 2001, 70, 1-20.
63. Barratt, G. Cell. Mol. Life Sci. 2003, 60, 21-37.
64. Peppas, L.B. Int. J. Pharm., 1995, 116, 1-9.
65. Lin, W.; Coombes, A.G.; Davies, M.C.; Davies, S.S.; Illum, L. J. Drug Targeting, 1993, 1, 237-243.
66. Zimmer, A.; Mutschler, E.; Lambrecht, G.; Mayer, D.; Kreuter, J. Pharm Res., 1994, 11, 1435-1442.
67. Merodio, M.; Arnedo, A.; Renedo, M.J.; Irache, J.M. Eur. J. Pharm. Sci., 2001, 12, 251-259.
68. Morimoto, Y.; Fujimoto, S. Crit. Rev. Ther. Drug Carrier Syst., 1985, 2, 19-63.
69. Rhodes, B.A.; Zolle, I.; Buchanan, J.W.; Wagner, H.N.J. Radiology, 1969, 92, 1453-1460.
70. Arshadi, R. J. Controlled Release, 1990, 14 111-131.
71. Geselowitz, D.A.; Neckers, L.M. Antisense Res. Dev., 1995, 5, 213-217.
72. Faulds, D.; Heel, H.C. Drugs of the Future, 1990, 13, 477-479.
73. McSharry, J.J.; Lurain, N.S.; Drusano, G.L.; Landay, A.L.; Notka, M.; O'Gorman, M.R.G.; Weinberg, A.; Shapiro, H.M.; Reichelderfer, P.S.; Crumpacker, C.S. Antimicrob. Agents Chemother., 1998, 42, 2326-2331.
74. Stuart, P.M.; Usui, N.; Randhawa, R.S.; Laycock, K.A.; Flemming T.P.; Pepose, J.S. Current Eye Res., 1997, 16, 496-502.
75. Boechk, M.; Boivin, G. Clin. Microbiol. Rev., 1998 11, 533-554.
76. Jacobson, J.G.; Renau, T.E.; Reza, M.; Sweir, D.; Breitenbach, J.M.; Townsend, L.B.; Drach, J.C. Antimicrob. Agents Chemother., 1999, 43, 1888-1894.
77. Bakker-Woudenberg, I.A.; Lokerse, A.F.; Ten Kate, M. Scan. Infect. Dis., 1990, S74, 54-57.
78. Duke, A.E.; Matthews, T.R. Antiviral Res., 1986, 6, 299-308.
79. Mocarski, E.S. Jr. In Fields Virology; Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., Martin, M.A., Roizman, B., Straus, S.E., Ed.; Lippincott-Reven: Philadelphia, 1996; Vol. 2 pp. 2447-2492.
80. Mattthews, T.; Boehme, R. Rev. Infect. Dis., 1988 10, S490-S494.
81. Merodio, M.; Espuelas, M.S.; Mirshahi, M.; Arnedo, A.; Irache, J.M. J. Drug Targeting, 2002, 10, 231-238.
82. Merodio, M.; Campanero, M.A.; Mirshahi, T.; Mirshahi, M.; Irache, J.M. J. Chromatog. A, 2000, 870, 159-167.
83. Desai, M.P.; Labhasetwar, V.; Walter, E.; Levy, R.J.; Amidon, G.L. Pharm. Res., 1997, 14, 1568-1573.
84. Tabata, Y.; Ikada, Y. Adv. Polymer Sci., 1990, 94, 107-141.
85. Haberkorn, U.; Khazai, K.; Morr, I; Altmann, A.; Muller, M.; van Kaick, G., Nucl. Med. Biol., 1998, 25, 367-373.
86. Jarvis, S.M.; Martin, B.W. Can. J. Physiol. Pharmacol., 1986, 64, 193-198.
87. Srinivasan, S.K.; Tewary, H.K.; Iversen, P.L. Antisense Res. Dev., 1995, 5, 131-139.
88. Arnedo, A.; Espuelas, S.; Irache, J.M. Int. J. Pharm., 2002, 244, 59-72.
89. Lambert, G.; Fattal, E.; Pinto-Alphandary, H.; Gulik, A.; Couvreur, P. Pharm. Res., 2000, 17, 707-714.
90. Simoes, S.; Slepushkin, V.; Pires, P.; Gaspar, R.; Pedroso de Lima, M.C.; Düzgünes, N. Biochim. Biophys. Acta, 2000, 1463, 459-469.
91. Garcia, L.A.; Araujo, P.S.; Chaimovich, H. Biochim. Biophys. Acta, 1984, 772, 231-234.
92. Sato, Y.; Kaneko, K.; Mikami, K.; Mizugaki, M.; Suzuki, Y. Biol. Pharm. Bull., 1999, 22, 1360-1365.
93. Schenkman, S.; Araujo, P.S.; Dijkman, R.; Quina, F.H.; Chaimovich H. Biochim. Biophys. Acta, 1981, 649, 633-647.
94. Peters, T. Jr. Adv. Protein Chem., 1985, 37 161-245.
95. Juliano, R.L; Alahari, S.; Yoo, H.; Kole, R.; Cho, M. Pharm. Res., 1999, 16, 494-502.
96. Crooke, S.T. Biotechnology, 1992, 10, 882-886.
97. Axel, D.I.; Spyridopoulos, I; Riessen, R.; Runge, H.; Viebahn, R.; Karsch, K.R. J. Vasc. Res., 2000, 4, 1018-1032.
98. Bennett, C.F. Biochem. Pharmacol., 1998, 55 9-19.
99. Stein, C.A. Biochim. Biophys. Acta, 1999, 1489 45-52.
100. Beltinger, C.; Saragovi, H.; Smith, R.; LeSauteur, L.; Shah, N.; De Dionisio, L.; Christensen, L.; Raible, A.; Jarett, L.; Gewirtz, A. J. Clin. Invest., 1995, 95, 1814-1823.
101. Maurice, D.M.; Mishima, S. In Handbook of experimental pharmacology; Sears ML, Ed.; Springer-Verlag: Berlin-Heidelberg, 1984; Vol. 69, pp. 19-116.
102. Giordano, G.G.; Refojo, M.F.; Arroyo, M.H. Ophthalmol. Vis. Sci., 1993, 34, 2743-2751.
103. Giordano, G.G.; Chevez-Barrios, P.; Refojo, M.F.; Garcia, C.A. Curr. Eye Res., 1995, 14, 761-767.
104. Caspi, R.R.; Chan, C.C.; Leake, W.C.; Higuchi, M.; Wiggert, B.; Chader, G.J. J. Autoimmun., 1990, 3, 237-246.
105. de Kozak, Y.; Mirshahi, M.; Boucheix, C.; Faure, J.P. Eur. J. Immunol., 1989, 17, 541-547.
106. Mirshahi, M.; Faure, J.P.; Brisson, P.; Falcon, J.; Guerlotté, J.; Collin, J.P. Biol. Cell., 1984, 52, 195-198.
107. Schalken, J.J.; Winkens, H.J.; van Vugt, A.H.M.; Bovée-Geurts, P.H.M.; de Grip, W.J.; Broekhuyse, R.M. Exp. Eye Res. 1988, 47, 135-145.
108. Hicks, D.; Molday, R.S. Exp. Eye Res., 1986, 42, 55-71.
109. Chader, G.J. Invest. Opthalmol. Vis. Sci., 1989, 30, 7-22.
110. Merodio, M.; Irache, J.M.; Valamanesh, F.; Mirshahi, M. Biomaterials, 2002, 23, 1587-1594.